Bristol Myers Squibb · 1 day ago
Documentation (QC) Specialist
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. They are seeking a Documentation (QC) Specialist to manage commercial specifications and methods, ensuring compliance and quality in documentation for client drug products and substances.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Manage commercial specifications and methods to ensure clear, correct, concise, consistent, and compliant documentation
Review and execute change proposals for GTS documents
Perform quality approval of GTS documents
Maintain the GTS system, including managing notification templates and obsolescing documents that are no longer in use
Qualification
Required
Minimum of a bachelors degree is required
Minimum 4 years experience in the pharmaceutical industry or related field
Cross-functional experience in two or more areas (e.g. research, analytical/QC, QA, stability, supply chain, manufacturing, CMC, IT, etc.)
Knowledge of specifications/methods, compendia, cGMP requirements, and regulatory expectations
Document management experience in a systems-related environment
Change management experience
Experience with SAP or Lab Information Management systems
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
Company data provided by crunchbase